Related Experiment Video

Updated: Aug 13, 2026

Chronic, Acute, and Reactivated HIV Infection in Humanized Immunodeficient Mouse Models
09:54

Chronic, Acute, and Reactivated HIV Infection in Humanized Immunodeficient Mouse Models

Published on: December 3, 2019

[HCV reinfection after liver transplantation for HCV cirrhosis]

G Pasquale1, P Iannicelli, S Martini

  • 1Dipartimento di Medicina Pubblica, Clinica e Preventiva, Sezione Malattie Infettive, Seconda Universita degli Studi di Napoli, Italy.

Le Infezioni in Medicina
|January 3, 2006
PubMed

Insights

Hepatitis C virus (HCV) recurrence after liver transplantation is common and reduces survival. Current treatments like interferon and ribavirin have limitations, with many questions remaining about optimal therapy for recurrent HCV infection.

Area of Science:

  • Hepatology
  • Virology
  • Transplantation Immunology

Context:

  • Hepatitis C virus (HCV) infection is the leading cause of liver transplantation.
  • Recurrence of HCV post-transplantation significantly impacts patient and graft survival.
  • Risk factors for recurrent HCV disease severity are linked to viral, host, and donor characteristics.

Purpose:

  • To review the challenges and therapeutic strategies for managing recurrent hepatitis C virus infection after orthotopic liver transplantation (OLT).
  • To highlight the high incidence of HCV recurrence and its detrimental effects on long-term outcomes.
  • To discuss current treatment limitations and identify areas needing further research.

Summary:

  • Recurrent HCV infection occurs in all pre-transplant positive patients and affects 75-80% post-OLT, leading to graft cirrhosis in one-third within 5-7 years.
  • Cholestatic hepatitis C can cause rapid graft failure, significantly reducing survival rates compared to other OLT indications.
  • Standard treatments involve interferons and ribavirin, but Peg-interferons are limited by side effects, and optimal treatment timing, targets, and duration remain unclear.

Impact:

  • Understanding recurrence patterns and risk factors is crucial for improving post-transplant management.
  • Identifying effective and safe therapeutic strategies is essential to enhance long-term graft and patient survival after OLT for HCV.
  • Further research is needed to clarify optimal treatment protocols for recurrent HCV infection in the allograft.

More Related Videos

Stem Cell-Derived Viral Ag-Specific T Lymphocytes Suppress HBV Replication in Mice07:25

Stem Cell-Derived Viral Ag-Specific T Lymphocytes Suppress HBV Replication in Mice

Published on: September 25, 2019

Related Concept Videos

Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Viral Hepatitis I: Introduction01:28

Viral Hepatitis I: Introduction

Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...
Retrovirus Life Cycles01:10

Retrovirus Life Cycles

Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the retrovirus to...
Cytomegalovirus Disease01:27

Cytomegalovirus Disease

Cytomegalovirus (CMV) disease is caused by human cytomegalovirus, a double-stranded DNA virus of the Herpesviridae family. While primary CMV infection is often asymptomatic in immunocompetent individuals, the virus can cause severe disease in neonates and immunocompromised patients. CMV is the most common cause of congenital viral infection in the United States, and a major pathogen in solid organ and hematopoietic stem cell transplant recipients.CMV is transmitted via bodily fluids, sexual...
Cirrhosis II: Pathophysiology01:24

Cirrhosis II: Pathophysiology

Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...
Cirrhosis I: Introduction01:23

Cirrhosis I: Introduction

Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...